Recombinant Human GAT1 Protein (HEK293)

GAT1, also known as the GABA transporter 1, is a critical protein in the central nervous system that is responsible for the reuptake of gamma-aminobutyric acid (GABA), the primary inhibitory neurotransmitter in the brain. The regulation of GABA levels is essential for maintaining the balance between excitation and inhibition in neuronal signaling, making GAT1 a significant target for the treatment of various neurological disorders, including epilepsy, anxiety, and depression. Understanding the structure and function of GAT1 at the molecular level can provide insights into its role in synaptic transmission and help identify new therapeutic strategies. Recent advances in recombinant protein technology have enabled researchers to produce and purify GAT1 extensively, facilitating the investigation of its biophysical properties and interaction with pharmacological agents. These studies are critical for elucidating the mechanisms of GABA transport and identifying potential drug candidates that could modulate GAT1's activity, thereby offering new avenues for drug development to address GABAergic dysfunctions in various psychiatric and neurological conditions. As a result, the research into GAT1 recombinant proteins not only plays a vital role in basic neuroscience but also has significant implications for therapeutic interventions targeting neurotransmitter systems in the brain.